(Q88558587)
Statements
Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment (English)
Teiji Kuzuya
Masatoshi Ishigami
Yoji Ishizu
Takashi Honda
Kazuhiko Hayashi
Tetsuya Ishikawa
Isao Nakano
Yoshiki Hirooka